About
Team
Management Team
Supervisory Board
Scientific Advisory Board
Erasmus MC Partner
Science
How TCR-T cell therapy works
Next-generation T cell therapy
Pipeline
Investors
News
Contact
Pan Cancer T celebrates 1-year anniversary!
Pan Cancer T celebrates 1-year anniversary!
Pan Cancer T B-day_2021 (2)
Related posts
16 januari 2025
Pan Cancer T BV extends partnership with NecstGen BV by initiating retroviral vector development
Read more
11 juli 2024
Pan Cancer T secures eur 4.25 Million in Seed Extension Round to advance next-generation T cell therapies
Read more
9 juli 2024
Erasmus MC together with Pan Cancer T receive KWF-PPS grant to develop next-generation T cell therapy
Read more
TCR T cells towards solid tumors: perspective on pitfalls and opportunities
1 september 2021
Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital
28 oktober 2021
